The half-year results of Australia-based multinational hospital group Ramsay Health Care were received positively by investors as revenue, profit and EBITDA all saw a jump.
Despite its reputation for excellent public healthcare and an economy as close to socialist as a capitalist country can be, private medical insurance (PMI) is on the up in Scandinavia. HBI speaks to three operators to find out more.
Last week we reported that some operators had expressed concerns after the Danish government made a new outsourcing agreement with the private hospital sector. This week we hear from operators more supportive of the development, who are keen to share a different perspective.
The Danish government has set out plans to increase its use of the private hospital sector. Those plans will see for-profit operators allowed to treat publicly-funded patients more, but also include significant tariff cuts.
Private medical insurance (PMI) plans are on the increase in the Nordic nations, Sweden, Denmark, Norway and Finland. Longer public health waiting times and incentives in employment contracts are the main reasons. HBI investigates.
Ambea Group, a major quoted Scandinavian care provider, has been actively buying social care companies in Denmark. We look at why Ambea has been buying in a country which has a history of hostility to for-profit health care and now has a leftist, Social Democrat government.
Ramsay Santé, the European branch of multinational hospital giant Ramsay Healthcare, has made a bid for listed Swedish specialty care provider GHP Specialty Care.
Clinisys claims to have created the world’s largest player in lab information management and lab order comms and results software with a three-way merger which creates a platform across diagnostics and environmental tests. So how does CEO, Michael Simpson, see software changing the sector over the next 3-5 years? And what does an independent consultant with many years experience in the field think about the sector and its growth?
Australia-based listed fertility specialist Virtus Health, which also has a footprint in Ireland, Denmark, the UK and Singapore, is the subject of a takeover bid. HBI speaks to an operator source to find out more about the prospects of one of the largest international fertility groups delisting.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
